Sign In
Buy DYAI
$1.05
-0.0200 (-1.87%)
At Close: Jul 31, 2026
Global Biocatalysis & Biocatalyst Market Trends, Forecast and Competitive Analysis to 2024 - ResearchAndMarkets.com
12:00am, Friday, 12'th Jun 2020
The
DYAI: Another Partnership, Another Step Closer to Immunizing the World
12:12pm, Thursday, 11'th Jun 2020
By John Vandermosten, CFA NASDAQ:DYAI Dyadic Announces Partnership with FNLCR Dyadic International, Inc. (NASDAQ:DYAI) announced in a press release yesterday that Frederick National Laboratory will us
6 Stocks And Targets To Watch
12:00am, Thursday, 11'th Jun 2020
Stocks Analysis by Harry Boxer covering: SPDR S&P 500, Ballard Power Systems Inc, Tesla Inc, Riot Blockchain Inc. Read Harry Boxer's latest article on Investing.com
Noble Financial Keeps a Buy Rating on Dyadic International (DYAI) - Markets
09:18pm, Wednesday, 10'th Jun 2020
In a report released today, Ahu Demir from Noble Financial reiterated a Buy rating on Dyadic International (DYAI – Research
Dyadic and Frederick National Laboratory to Develop Cell Lines for COVID-19 Vaccine Candidates Using Dyadic's C1 Gene Expression Platform
12:30pm, Wednesday, 10'th Jun 2020
JUPITER, FL / ACCESSWIRE / June 10, 2020 / Dyadic International, Inc. ("Dyadic" or the "Company") (DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 ge
DYAI: Steady as She Goes
10:10am, Friday, 29'th May 2020
By John Vandermosten, CFA NASDAQ:DYAI READ THE FULL DYAI RESEARCH REPORT First Quarter Financial & Operational Results Dyadic International Inc. (NASDAQ: DYAI) released first quarter financial and ope
Hedge Funds Cashed Out Of Dyadic International, Inc. (DYAI)
04:43pm, Wednesday, 27'th May 2020
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of Ma
Edited Transcript of DYAI earnings conference call or presentation 14-May-20 9:00pm GMT
04:50pm, Friday, 15'th May 2020
Q1 2020 Dyadic International Inc Earnings Call
Dyadic International, Inc. (DYAI) CEO Mark Emalfarb on Q1 2020 Results - Earnings Call Transcript
03:44am, Friday, 15'th May 2020
Dyadic International, Inc. (NASDAQ:DYAI) Q1 2020 Earnings Conference Call May 14, 2020, 05:00 PM ET Company Participants Ping Rawson - CFO Mark Emalfarb - Presi
Dyadic Reports 2020 First Quarter Results and Recent Developments
08:00pm, Thursday, 14'th May 2020
Two fully funded research projects with top four animal health companies. Nonexclusive research license agreement with WuXi Biologics. Feasibility study with the University of Oslo on influenza vaccin
We're Hopeful That Dyadic International (NASDAQ:DYAI) Will Use Its Cash Wisely
12:03pm, Friday, 01'st May 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Dyadic to Report First Quarter 2020 Financial Results on Thursday, May 14, 2020
08:00pm, Thursday, 30'th Apr 2020
JUPITER, FL / ACCESSWIRE / April 30, 2020 / Dyadic International, Inc. ("Dyadic") (DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system
Dyadic to Present and Participate in COVID-19 Panel at the Planet MicroCap Showcase Virtual Investor Conference 2020
12:00pm, Monday, 20'th Apr 2020
JUPITER, FL / ACCESSWIRE / April 20 , 2020 / Dyadic International, Inc. ("Dyadic", or the "Company") (NASDAQ:DYAI) a global biotechnology company focused on further improving and applying ...
DYAI: New Alliance with Chinese CDMO
11:00am, Wednesday, 08'th Apr 2020
By John Vandermosten, CFA NASDAQ:DYAI READ THE FULL DYAI RESEARCH REPORT Full Year 2019 Financial & Operational Results Dyadic International Inc. (NASDAQ: DYAI) released full year 2019 financial and o
Edited Transcript of DYAI earnings conference call or presentation 30-Mar-20 9:00pm GMT
09:06am, Tuesday, 31'st Mar 2020
Q4 2019 Dyadic International Inc Earnings Call
